MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
-12.94%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$88.4M
AUM Growth
+$88.4M
(-16%)
Cap. Flow
+$6.91M
Cap. Flow
% of AUM
7.81%
Top 10 Holdings %
Top 10 Hldgs %
95.54%
Holding
14
New
–
Increased
4
Reduced
2
Closed
–
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$4.53M |
| 2 |
TG Therapeutics
TGTX
|
$3.54M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.26M |
| 4 |
Stoke Therapeutics
STOK
|
$417K |
Top Sells
| 1 |
Arrowhead Research
ARWR
|
$1.94M |
| 2 |
BridgeBio Pharma
BBIO
|
$1.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $30.1M | 34.03% | 6,950,000 +1,046,595 | +18% | +$4.53M |
|
2
Rocket Pharmaceuticals
RCKT
$354M
| $12.4M | 13.99% | 722,080 | – | – |
|
3
Invivyd
IVVD
$204M
| $11.1M | 12.55% | 9,248,250 | – | – |
|
|
4
TG Therapeutics
TGTX
$4.65B
| $5.11M | 5.77% | 339,500 +235,100 | +225% | +$3.54M |
|
|
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
| $5.09M | 5.75% | 197,700 +87,800 | +80% | +$2.26M |
|
|
6
BridgeBio Pharma
BBIO
$9.89B
| $5.05M | 5.71% | 304,700 -114,300 | -27% | -$1.9M |
|
7
Ionis Pharmaceuticals
IONS
$6.79B
| $4.51M | 5.1% | 126,300 | – | – |
|
|
8
Stoke Therapeutics
STOK
$1.08B
| $4.44M | 5.02% | 532,890 +50,000 | +10% | +$417K |
|
9
ProQR Therapeutics
PRQR
$237M
| $4.07M | 4.6% | 1,910,600 | – | – |
|
10
Curis
CRIS
$20.9M
| $2.67M | 3.02% | 4,482,142 | – | – |
|
|
11
Arrowhead Research
ARWR
$3.05B
| $1.71M | 1.94% | 67,400 -76,500 | -53% | -$1.94M |
|
12
Atara Biotherapeutics
ATRA
$84.6M
| $1.27M | 1.44% | 439,300 | – | – |
|
|
SLN
13
Silence Therapeutics
SLN
$227M
| $905K | 1.02% | 145,900 | – | – |
|
|
NEXI
14
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $50.7K | 0.06% | 133,442 | – | – |
|